2[1]Calvert H.An overview of folate metabolism:Features relevant to the action and toxicities of antifolate anticancer agents.Semin Oncol,1999,26 (2 Suppl 6):3
3[2]Castagneto B,Mencoboni M,Degiovanni D,et al.Pemetrexed (MTA) and carboplatin (CBDCA) in the treatment of advanced pleural mesothelioma (MPM).Proc ASCO,2006,Abs 7093
4[3]Marino A,Pinto C,Mutri V,et al.Neoadjuvant chemotherapy followed by extrapleural pneumonectomy (EPP) for malignant pleural mesothelioma (MPM):An Italian experience with cisplatin-based regimens.Proc ASCO,2006,Abs 17022
5[4]Karthaus M,Frieler F,Vasquez N,et al.Pemetrexed(A) /platinum for patients with advanced malignant peritoneal mesothelioma (AbM):The Bielefeld Experience.Proc ASCO,2006,Abs 4151
6[5]Simon GR,Janne PA,Langer C,et al.A.Dowlati,et al.A finalized phase Ⅱ report of pemetrexed (P) plus gemcitabine (G) as front -line chemotherapy for patients with peritoneal mesothelioma (PM).Proc ASCO,2006,Abs 2050
7[6]Demarinis F,Paul S,Hanna N,et al.Survival update for the phase Ⅲ study of pemetrexed vs docetaxel in non-small cell lung cancer (NSCLC).Proc ASCO,2006,Abs 7133
8[7]Fossella FV,Berry DA,Adachi S,et al.Survival in previously treated advanced NSCLC:Pemetrexed versus best supportive care (BSC).Proc ASCO,2006,Abs 17015
9[8]West HJ,Belt RJ,Wakelee HA,et al.Front line therapy with gemcitabine (G) administered immediately prior to pemetrexed (P) for patients (pts) with advanced or metastatic non-small cell lung cancer (NSCLC):Final report of a phase Ⅱ clinical trial.Proc ASCO,2006,Abs 7116
10[9]Dudek A,Larson T,McCleod M,et al.Initial results of a phase Ⅱ study of biweekly pemetrexed and gemcitabine in patients with advanced NSCLC.Proc ASCO,2006,Abs 7128
4Sugarbaker PH, Yan H, Grazi RV, et al. Earlylocalized perito heal mesothelioma as an incidental finding at laparoscopy. Report of a case and implications regarding natural history of the disease [ J ]. Cancer,2000,89 : 1279 - 1284.
7Krasuski P, Ponieeka A, Gal E. The diagnostic challenge of peritoneal mesothelioma . Arch Gynecol Obstet, 2002,266 : 130- 132.
8Yah TD, Welch L, Black D, et al. A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma. Ann Oncol,2007,18 : 827-834.
